Not Signed In -
Bupropion |
Wellbutrin |
Clinical Trial: Maintenance Treatment for Abstinent Smokers - 1
This study is currently recruiting patients.
Purpose
The purpose of this study is to determine the efficacy and cost-effectiveness of long-term pharmacotherapy (using Zyban and/or nicotine replacement) for reducing the relapse rate associated with stopping smoking.
| Condition | Treatment or Intervention |
|---|---|
| Tobacco Use Disorder | Drug: Bupropion |
MedlinePlus related topics: Smoking
Study Type: Interventional
Study Design: Treatment, Uncontrolled, Parallel Assignment
Official Title: Maintenance treatment for Prevention of Smoking Relapse
Further Study Details:
Expected Total Enrollment: 750
Study start: August 2000
Eligibility
Ages Eligible for Study: 21 Years - 75 Years, Genders Eligible for Study: Both
Accepts Healthy Volunteers
Criteria
Inclusion Criteria:
- Patients who smoke at least 10 cigarettes daily and have attempted to quit smoking at least once
Exclusion Criteria:
- Seizure History
- Unstable Blood Pressure
- Current major depression
- Current alcohol/drug abuse or dependency
- Lifetime psychotic illness
- Current use of psychotropic drugs
- Unstable medical condition
Location and Contact Information
Lirio S. S Covey, Ph.D. (212)543-5736 lsc3@columbia.edu
New York
New York State Psychiatric Institute, New York, New York, 10032, United States; Recruiting
Lirio S. S Covey, Ph.D. 212-543-5736 lsc3@columbia.edu
Study chairs or principal investigators
Lirio S. S Covey, Ph.D., Principal Investigator, Research Foundation for Mental Hygiene, Inc.
More Information
Study ID Numbers: NIDA-13490-1; R01-13490-1
Record last reviewed: June 2003
Last Updated: February 16, 2005
Record first received: June 25, 2003
ClinicalTrials.gov Identifier: NCT00063323
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Record last reviewed: June 2003
Last Updated: February 16, 2005
Record first received: June 25, 2003
ClinicalTrials.gov Identifier: NCT00063323
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
email this page
print this page
bookmark this page
feedback on this page
